Macular oedema linked to latanoprost and rosiglitazone.
D000959:Antihypertensive Agents / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077338:Latanoprost; D008269:Macular Edema / Q000139:chemically induced*; D011461:Prostaglandins F, Synthetic / Q000009:adverse effects*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D011461:Prostaglandins F, Synthetic; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077338:Latanoprost